NCT02885194

Brief Summary

Pain is a common symptom of Parkinson's disease (PD) but the physiology remains poorly understood. Recent work suggests that subthalamic nucleus deep brain stimulation (STN-DBS) could make a profit on the pain in PD. The investigator would drive a study with a follow up of PD patients before and after STN-DBS. The pain will be clinically explored by targeted questionnaires and electrophysiological through laser evoked potentials. The questionnaires are designed to quantify and characterize the pain in these patients. Laser evoked potentials will, through repetitive stimulation, study both the functional status of the afferent nociceptive pathways, their habituation to repetitive nociceptive stimuli, and so better understand any abnormalities of the central processing of nociceptive information.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 31, 2016

Completed
Last Updated

October 13, 2016

Status Verified

October 1, 2016

Enrollment Period

1.3 years

First QC Date

August 26, 2016

Last Update Submit

October 12, 2016

Conditions

Keywords

Parkinson DiseasePainDeep Brain StimulationLaser-Evoked Potentials

Outcome Measures

Primary Outcomes (1)

  • Modification of habituation in percentage, between tests performed before and after DBS

    The habituation is the change of amplitude between the first and the second response of the double stimulation during the laser evoked potential. We calculated a percentage

    After the second laser evoked potential which occurred around 3 months after STN-DBS

Secondary Outcomes (2)

  • Change in latency of laser evoked potential responses before and after DBS

    After the second laser evoked potential which occurred around 3 months after STN-DBS

  • Change in amplitude of laser evoked potential responses before and after DBS

    After the second laser evoked potential which occurred around 3 months after STN-DBS

Study Arms (1)

Patients who underwent Deep Brain Stimulation (DBS)

OTHER

Patients who underwent Subthalamic Nucleus (STN)-DBS at Lyon

Other: Laser-Evoked potential

Interventions

Laser-Evoked potential can document lesions of spinothalamic tract and lateral brainstem and of thalamo-cortical projections conducting nociceptive signals. The rapid heating of skin by infrared laser pulses stimulate small fibers sensory pathways. The main cortical laser evoked potential is a complex of components N2-P2. Evaluation of the registered potentials includes shape, latency and amplitude.

Patients who underwent Deep Brain Stimulation (DBS)

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A patient with idiopathic Parkinson's disease
  • Age between 30 and 70 inclusive.
  • No cognitive decline (MMS greater than or equal to 24)
  • Normal brain MRI
  • Informed consent signed
  • With or without pain sensation

You may not qualify if:

  • Presence of other neurological pathology that could explain the pain.
  • MMS less than 24
  • Pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Neurologie C, Hôpital Neurologique, HCL

Bron, 69500, France

Location

MeSH Terms

Conditions

Parkinson DiseasePain

Interventions

Laser-Evoked Potentials

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Evoked Potentials, SomatosensoryEvoked PotentialsCortical ExcitabilityElectrophysiological PhenomenaPhysiological PhenomenaNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Stéphane THOBOIS, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2016

First Posted

August 31, 2016

Study Start

January 1, 2015

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

October 13, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations